Prevention of Contrast-Induced Nephropathy With Oxygen Supplementation a Randomized Controlled Trial Pubmed



Minoo F^{1, 2} ; Lessanpezeshki M^{1, 2} ; Firouzi A³ ; Nikfarjam S⁴ ; Gatmiri SM^{1, 2} ; Ramezanzade E⁵ Show Affiliations
Source: Iranian Journal of Kidney Diseases Published:2016

Abstract

Introduction. The aim of the study was to investigate the efficacy of nasal oxygen as a supplementation to hydration therapy in reducing the risk of developing contrast-induced nephropathy (CIN). Materials and Methods. In a randomized controlled trial, 348 patients scheduled to undergo elective coronary angiography were randomly allocated to standard hydration plus 2 L/min to 3 L/ min nasal oxygen (from 10 minutes before the procedure until the end of the procedure) (n = 176) or standard hydration alone (n = 176). The primary outcome measure was development of CIN defined as either an increase of 25% or more in serum creatinine concentrations or an increment of at least 0.5 mg/dL in serum creatinine concentrations 48 hours after catheterization. Results. Of the 348 patients who completed the study, 105 developed CIN (30.2%; 95% confidence interval, 25.4% to 35.0%). A diagnosis of CIN was made in 32 (18.6%) and 73 (41.5%) patients in the nasal oxygen and control arms, respectively (P <.001). In the intervention arm, creatinine concentrations postcontrast remained relatively constant (average change, 2.7%), whereas a significant increase of 17.3% was recorded in the control arm (P <.001; effect size, 11.8%). Conclusions. Supplementation with nasal oxygen in addition to standard hydration appears to be an effective strategy in reducing CIN. The effect size for this intervention seems to be moderate. © 2016, Iranian Society of Nephrology. All rights reserved.